BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1548249)

  • 1. Possible trazodone potentiation of fluoxetine: a case series.
    Nierenberg AA; Cole JO; Glass L
    J Clin Psychiatry; 1992 Mar; 53(3):83-5. PubMed ID: 1548249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
    Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
    J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative trial of fluoxetine versus trazodone in outpatients with major depression.
    Perry PJ; Garvey MJ; Kelly MW; Cook BL; Dunner FJ; Winokur G
    J Clin Psychiatry; 1989 Aug; 50(8):290-4. PubMed ID: 2668259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
    Schatzberg AF; Dessain E; O'Neil P; Katz DL; Cole JO
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):44S-49S. PubMed ID: 3123528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action.
    Marek GJ; McDougle CJ; Price LH; Seiden LS
    Psychopharmacology (Berl); 1992; 109(1-2):2-11. PubMed ID: 1365657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of fluoxetine on symptoms of insomnia in depressed patients.
    Satterlee WG; Faries D
    Psychopharmacol Bull; 1995; 31(2):227-37. PubMed ID: 7491373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trazodone for antidepressant-associated insomnia.
    Nierenberg AA; Adler LA; Peselow E; Zornberg G; Rosenthal M
    Am J Psychiatry; 1994 Jul; 151(7):1069-72. PubMed ID: 8010365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More on combination antidepressant therapy.
    Zimmer B; Daly F; Benjamin L
    Arch Gen Psychiatry; 1984 May; 41(5):527. PubMed ID: 6721675
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
    Byerley WF; Reimherr FW; Wood DR; Grosser BI
    J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of monoamine oxidase inhibitor-associated insomnia with trazodone.
    Nierenberg AA; Keck PE
    J Clin Psychopharmacol; 1989 Feb; 9(1):42-5. PubMed ID: 2708555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient drug attributions and postmarketing surveillance.
    Fisher S; Bryant SG; Kent TA; Davis JE
    Pharmacotherapy; 1994; 14(2):202-9. PubMed ID: 8197040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study.
    Jacobsen FM
    J Clin Psychiatry; 1990 Jul; 51(7):298-302. PubMed ID: 2365668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing surveillance by patient self-monitoring: trazodone versus fluoxetine.
    Fisher S; Bryant SG; Kent TA
    J Clin Psychopharmacol; 1993 Aug; 13(4):235-42. PubMed ID: 8376610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of double depression: a preliminary study with serotonergic antidepressants.
    Hellerstein DJ; Yanowitch P; Rosenthal J; Hemlock C; Kasch K; Samstag LW; Winston A
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):139-47. PubMed ID: 8115668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.